Finance
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
009420
Research
009420:KRX
check_indeterminate_small
Hanall Biopharma Co Ltd
â‚©59,700.00
arrow_downward
-7.59%
(
-4,900.00
) 1D
Aug 31, 3:30:21 PM GMT+9 · KRW
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
Earnings
Financials
insights_auto
Generating top insights for 009420...
Open
â‚©61,000
High
â‚©61,000
Low
â‚©57,000
Mkt. cap
3.12T
Avg. vol.
343.35K
Volume
390.50K
52-wk high
â‚©73,000
52-wk low
â‚©28,950
EPS
-â‚©490
Shares outstanding
52.24M
No. of employees
304
Open
â‚©61,000
High
â‚©61,000
Low
â‚©57,000
Mkt. cap
3.12T
Avg. vol.
343.35K
Volume
390.50K
52-wk high
â‚©73,000
52-wk low
â‚©28,950
EPS
-â‚©490
Shares outstanding
52.24M
No. of employees
304
Related stocks
064550
Bioneer Corp
â‚©8,790.00
+5.78%
arrow_upward
068760
Celltrion Pharm Inc
â‚©41,700.00
-2.11%
arrow_downward
128940
Hanmi Pharm Co Ltd
â‚©492,500.00
-3.24%
arrow_downward
069620
Daewoong Pharma
â‚©127,000.00
-1.40%
arrow_downward
About Hanall Biopharma Co Ltd
CEO
Yoon Jae-chun | Seung Kook Park
Employees
304
Founded
1973
Headquarters
Seoul, Gangnam District, South Korea
Sector
Pharmaceutical industry
Website
hanall.co.kr
Previous reports
All values in KRW
Loading Previous Earnings...
Income statement
Balance sheet
Cash flow
Income statement
Revenue
Net income
calendar_month
Quarterly
Quarterly
Annual
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
40.80B
37.55B
40.03B
44.28B
Cost of goods sold
19.78B
18.91B
18.72B
19.51B
Cost of revenue
19.78B
18.91B
18.72B
19.51B
Research and development expenses
4.77B
3.58B
3.52B
3.72B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.62B
16.79B
16.64B
15.15B
Operating expense
20.68B
21.35B
20.47B
19.32B
Total operating expenses
40.45B
40.26B
39.19B
38.83B
Operating income
348.88M
-2.71B
838.73M
5.45B
Other non operating income
66.15M
91.23M
566.24M
-10.89B
EBT including unusual items
342.71M
-7.16B
570.24M
-21.50B
EBT excluding unusual items
324.21M
-2.74B
570.24M
-5.85B
Income tax expense
43.75M
-912.20M
295.24M
-2.27B
Effective tax rate
12.77%
12.74%
51.77%
10.57%
Other operating expenses
170.57M
159.83M
178.41M
160.81M
Net income
298.96M
-6.25B
275.00M
-19.23B
Net profit margin
0.73%
-16.64%
0.69%
-43.43%
Earnings per share
-
-
-
-
Interest and investment income
62.64M
52.44M
138.01M
204.61M
Interest expense
-20.18M
-80.02M
-372.72M
-418.03M
Net interest expenses
42.46M
-27.59M
-234.71M
-213.42M
Depreciation and amortization charges
136.95M
129.60M
129.07M
125.27M
EBITDA
1.25B
-1.82B
1.67B
6.18B
Gain or loss from assets sale
-18.50M
-4.84M
-
319.09M
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Ask anything
edit_square
New thread
notes_spark
Thread history
What's going on with the markets today?
search_spark
Create a portfolio
add
Create a task
task_spark
Deep Search
travel_explore
mic
Voice Search
add
Add Tool
upload_file
Upload File
bar_chart
Create portfolio
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
mic
Voice Search
add
Add Tool
upload_file
Upload File
bar_chart
Create portfolio
travel_explore
Deep Search
arrow_upward
Ask AI
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer